Register Login

Urogen Pharma Inc (URGN)

  • SEC News
  • Sept. 09, 2025, 22:32 UTC
  • 0
  • 1 comments

Smith Jason Drew 🟡 adjusted position in 1.5K shares (1 derivative) of UroGen Pharma Ltd. (URGN) at $19.11 Transaction Date: Sep 07, 2025 | Filing ID: 028705

Comment Full text

Tourmaline Bio Inc (TRML)

  • SEC News
  • Sept. 09, 2025, 22:00 UTC
  • 0
  • 1 comments

KANTOFF AARON 🟡 adjusted position in 0 shares (2 derivative) of Tourmaline Bio, Inc. (TRML) at $9.46 Transaction Date: Sep 05, 2025 | Filing ID: 023997

Comment Full text

Avidity Biosciences Inc (RNA)

  • SEC News
  • Sept. 09, 2025, 21:53 UTC
  • 0
  • 1 comments

Director WILSON TROY EDWARD 🟡 adjusted position in 29.5K shares (1 derivative) of Avidity Biosciences, Inc. (RNA) at $50.00 ($1.8M) Transaction Date: Sep 05, 2025 | Filing ID: 000177

Comment Full text

BeiGene Ltd (BGNE)

  • SEC News
  • Sept. 09, 2025, 21:31 UTC
  • 0
  • 1 comments

Director Sanders Corazon (Corsee) D. 🟡 adjusted position in 34.6K shares (1 derivative) of BeOne Medicines Ltd. (ONC) at $337.00 ($1.7M) Transaction Date: Sep 05, 2025 | Filing ID: 000139

Comment Full text

MITESCO, INC. (MITI)

  • SEC News
  • Sept. 09, 2025, 21:28 UTC
  • 0
  • 0 comments

New Form 8-K - Mitesco, Inc. Filed: 2025-09-09 AccNo: 0001185185-25-001157 Size: 235 KB Item 1.01: Entry into a Material Definitive Agreement Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

Comment Full text

Envoy Medical Inc (COCH)

  • SEC News
  • Sept. 09, 2025, 21:26 UTC
  • 0
  • 0 comments

New Form 8-K - Envoy Medical, Inc. Filed: 2025-09-09 AccNo: 0001213900-25-086268 Size: 362 KB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits

Comment Full text

Search

News categories